Multiple Breath Washout as a Method for Diagnosing Lung Diseases
NCT ID: NCT06179342
Last Updated: 2024-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2021-06-21
2024-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Understand the Accuracy of a New Breathing Device Compared to Standard Testing for Asthma and COPD
NCT07253883
Number of Multiple Breath Washout Tests in Adults With Pulmonary Disease and Healthy Controls
NCT03176745
Evaluation of Novel Lung Function Parameters in Patients With Bronchial Asthma
NCT03820427
Recognition of Early Pulmonary Structural Changes by Using Real-time High Fidelity Expiratory CO2 Analysis
NCT05092035
Comparing Pressure Based and Dilution Based Total Lung Capacity Measurements in COPD Patients for Lung Function Diagnostics
NCT04531293
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It will also be tested whether the fact that the EasyOnePro®LAB measurement can be carried out largely independently of the employee also leads to better reproducibility of the results. To this end, the intra-individual deviations in repeated measurements will be compared between the methods.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cardiopulmonary healthy
Patients in whom there is no evidence of cardiopulmonary dysfunction in the course of diagnostics
Multiple-Breath-Washout
One additional diagnostic test is performed using the Multiple-Breath-Washout technology
Idiopathic pulmonary fibrosis
idiopathic pulmonary fibrosis (IPF), confirmed according to the guidelines
Multiple-Breath-Washout
One additional diagnostic test is performed using the Multiple-Breath-Washout technology
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) with/without emphysema
Multiple-Breath-Washout
One additional diagnostic test is performed using the Multiple-Breath-Washout technology
Asthma bronchiale
Multiple-Breath-Washout
One additional diagnostic test is performed using the Multiple-Breath-Washout technology
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multiple-Breath-Washout
One additional diagnostic test is performed using the Multiple-Breath-Washout technology
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* existing consent
* confirmed diagnosis of one of the following diseases
* idiopathic pulmonary fibrosis (IPF), confirmed according to the guidelines
* chronic obstructive pulmonary disease (COPD) with/without emphysema
* bronchial asthma
* or patients who are admitted with suspected cardiopulmonary dysfunction (e.g. with unclear dyspnoea) and in whom there is no evidence of cardiopulmonary dysfunction during the diagnostic process (comparison group of "healthy" patients).
* Indication for routine performance of the following pulmonary function tests during the current inpatient stay: Whole Body Plethysmography \& Diffusion Capacity of the Lung (single-breath)
Exclusion Criteria
* Simultaneous presence of at least two of the following diseases (IPF, COPD/emphysema, asthma, pulmonary arterial hypertension)
* any medical, psychological or other condition that restricts the patient's ability to give informed consent for voluntary participation in this trial
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boehringer Ingelheim
INDUSTRY
ndd Medizintechnik AG
INDUSTRY
Wissenschaftliches Institut Bethanien e.V
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lars Hagmeyer, PD Dr.
Role: PRINCIPAL_INVESTIGATOR
Wissenschaftliches Institut Bethanien e.V
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wissenschaftliches Institut Bethanien e.V.
Solingen, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WI_20-1542_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.